Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial Fibrillation

NCT04080830 | Unknown

• 1 other identifier: ID-8849
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Patient Registration Study of Acute Ischemic Stroke/transient ischemic attack(TIA) With Atrial Fibrillation (AISWAF) is a single-center prospective, consecutively, observational study, was conducted in patients with acute ischemic stroke/TIA with atrial fibrillation. The aim of this study was to understand the stroke mechanism, the regularity of stroke recurrence and its influencing factors, to establish a risk stratification model for stroke recurrence, and to preliminarily explore the relationship between stroke mechanism, risk stratification and antithrombotic regimen in this population.

Conditions

Acute Ischemic Stroke; Atrial Fibrillation

Keywords

Registration Study; Acute Ischemic Stroke; Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

• The rate of recurrent Ischemic stroke/TIA and symptomatic systemic embolism

  recurrent ischemic stroke/TIA and symptomatic systemic embolism

  one year

Secondary Outcomes (9)

• The rate recurrent Ischemic stroke/TIA

  one year

• The rate of symptomatic intracranial hemorrhage

  one year

• The rate of non-intracranial major hemorrhage

  one year

• the rate of hemorrhagic transformation and the rate of symptomatic hemorrhagic transformation

  one month

• the rate of vascular death

  one year

Study Arms (1)

Acute ischemic stroke/transient ischemic attack (TIA) with AF

patients with Acute ischemic stroke/TIA and Atrial fibrillation (observational -no intervention)

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Acute Ischemic Stroke/TIA With Atrial Fibrillation

You may qualify if:

• Age greater than or equal to 18 years old;
• Acute ischemic stroke or TIA within 14 days of onset (including patients with hemorrhagic transformation of infarction)
• Evidence of atrial fibrillation or newly discovered atrial fibrillation before onset (atrial fibrillation includes valvular and non-valvular, permanent, persistent or paroxysmal);
• Sign informed consent and consent to follow-up for 1 year.

Sponsors & Collaborators

• Xuanwu Hospital, Beijing: lead

Study Sites (1)

Sufang Xue

Beijing, Beijing Municipality, 100053, China

RECRUITING

MeSH Terms

Conditions

Ischemic Stroke; Atrial Fibrillation

Condition Hierarchy (Ancestors)

Stroke; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Arrhythmias, Cardiac; Heart Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

sufang xue, PHD，MD

CONTACT

8613810496895; xuesufang@xwhosp.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: September 3, 2019
• First Posted: September 6, 2019
• Study Start: January 1, 2016
• Primary Completion: December 30, 2021
• Study Completion: December 30, 2021
• Last Updated: September 10, 2019

Record last verified: 2019-09

Locations

CN (1)